BNF:

Infections

Status:

Red

Decision Date:

None

Comments

RED^1,2,3,8: NICE TA300 - Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people (decision date - December 2013)

RED: treatment of HBeAg-positive chronic hepatitis B infection (decision date - January 2018)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again